Citi is out with its report today on ECA Marcellus Trust I ECT, lowering its PT from $34 to $32.
In its report, Citi writes, "Our target price assumes applying an 11.0x trailing P/DCF multiple to our next twelve months' distributable cash flow forecast of $51.5 million. The change to our target price primarily reflects the downward adjustments to our commodity price assumptions."
Citi maintains Buy on ECT.
Shares of ECT closed Wednesday at $24.28, up 1.79% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in